External ESG Initiatives Consolidation and improvement of our score in the main ESG assessment systems: Score of 84/100, the Platinum Medal Top 1% of companies assessed ESG Risk Rating of 17.1, within the low-risk category Among the top 4% of companies within the pharmaceutical industry A- rating, Leadership in Climate Change B rating, Management in Water Security A- rating, Leadership in Supplier Engagement ESG Plan 2021-2023 In 2023, we completed the implementation of our first Sustainability Strategy, our ESG Plan 2021-2023. We met the vast majority of the ambitious objectives and milestones we had set for ourselves. Key achievements were: Definition and launch of Almirall's Net Zero Strategy, which includes science-based carbon reduction targets for 2030. Launch of our holistic corporate wellbeing programme "YouFeelWell." Implementation of our Sustainable Procurement Programme. Approval of a new anti-corruption and anti-bribery policy. Activation of our new "Speak Up" whistleblowing channel. Establishment of a corporate framework for social action. Pharmaceutical Supply Chain Initiative membership. Linking ESG targets to the variable remuneration of all members of Almirall’s Management Board. Inclusion of sustainability as a priority in the strategy with the 2022 approval of the ESG Dashboard. We are proud of our achievements in sustainability and we are determined to keep evolving our approaches for an even bigger impact in the future. We want to go one step further and transform the lives of patients with our products and continue to transform our organization and the impact we have on society and the planet. At Almirall, we see sustainability as a core pillar of our long-term vision and company ambition. We are committed to continuously enhancing our impact on people's lives and advancing our sustainability goals. TUV - ISOs Almirall’s Barcelona headquarters has achieved LEED certification for Operation and Maintenance of existing buildings in the gold category